3/19/2013

British researchers found that a drug that combines glucagon and glucagon-like peptide 1 hormones helped participants consume 200 fewer calories from a heavy meal. The drug, currently available only as an infusion, may be taken as a once-weekly injection and may be ready for general use by 2020, researchers said. The findings were to be presented at the Society for Endocrinology meeting.

Related Summaries